| Copper induces cell death by targeting lipoylated TCA cycle proteins P Tsvetkov, S Coy, B Petrova, M Dreishpoon, A Verma, M Abdusamad, ... Science 375 (6586), 1254-1261, 2022 | 2062 | 2022 |
| Discovering the anticancer potential of non-oncology drugs by systematic viability profiling SM Corsello, RT Nagari, RD Spangler, J Rossen, M Kocak, JG Bryan, ... Nature cancer 1 (2), 235-248, 2020 | 551 | 2020 |
| Mitochondrial metabolism promotes adaptation to proteotoxic stress P Tsvetkov, A Detappe, K Cai, HR Keys, Z Brune, W Ying, P Thiru, ... Nature chemical biology 15 (7), 681-689, 2019 | 352 | 2019 |
| Extracting biological insights from the project achilles genome-scale CRISPR screens in cancer cell lines JM Dempster, J Rossen, M Kazachkova, J Pan, G Kugener, DE Root, ... BioRxiv, 720243, 2019 | 302 | 2019 |
| Non-oncology drugs are a source of previously unappreciated anti-cancer activity SM Corsello, RT Nagari, RD Spangler, J Rossen, M Kocak, JG Bryan, ... BioRxiv, 730119, 2019 | 38 | 2019 |
| Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling. Nat Cancer. 2020; 1: 235–48 SM Corsello, RT Nagari, RD Spangler, J Rossen, M Kocak, JG Bryan | 6 | 2022 |
| Fine-mapping causal tissues and genes at disease-associated loci BJ Strober, MJ Zhang, T Amariuta, J Rossen, AL Price medRxiv, 2023 | 2 | 2023 |
| Adenosine receptor antagonists exhibit potent and selective off-target killing of FOXA1-high cancers SM Corsello, RD Spangler, R Humeidi, CN Harrington, RT Nagari, ... Cancer Research 80 (16_Supplement), 3400-3400, 2020 | 1 | 2020 |
| MultiSuSiE improves multi-ancestry fine-mapping in All of Us whole-genome sequencing data J Rossen, H Shi, BJ Strober, MJ Zhang, M Kanai, ZR McCaw, L Liang, ... medRxiv, 2024.05. 13.24307291, 2024 | | 2024 |
| Abstract B121: An oncogene-linked prodrug strategy in lung cancer A Boudreau, J Roth, J Rong, N Olsson, C Mader, J Byran, J Rossen, ... Molecular Cancer Therapeutics 18 (12_Supplement), B121-B121, 2019 | | 2019 |
| Massively parallel multiplexed methods to screen hundreds of barcoded cancer cell line models with small molecules or genetic perturbations using next-generation sequencing S Bender, C Zhu, L Wang, M Rothberg, J Dempster, B Paolella, M Kocak, ... Cancer Research 79 (13_Supplement), 2690-2690, 2019 | | 2019 |
| Novel cell line barcoding method reveals tepoxalin as a selective drug against MDR1-high tumor cells SM Corsello, RD Spangler, RT Nagari, M Kocak, J Rossen, P O'Hearn, ... Cancer Research 79 (13_Supplement), 2948-2948, 2019 | | 2019 |
